GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LungLife AI Inc (LSE:LLAI) » Definitions » Net Margin %

LungLife AI (LSE:LLAI) Net Margin % : -11,438.89% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is LungLife AI Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. LungLife AI's Net Income for the six months ended in Dec. 2023 was £-2.06 Mil. LungLife AI's Revenue for the six months ended in Dec. 2023 was £0.02 Mil. Therefore, LungLife AI's net margin for the quarter that ended in Dec. 2023 was -11,438.89%.

The historical rank and industry rank for LungLife AI's Net Margin % or its related term are showing as below:

LSE:LLAI' s Net Margin % Range Over the Past 10 Years
Min: -31225   Med: -3436.77   Max: -330.93
Current: -11894.44


LSE:LLAI's Net Margin % is ranked worse than
98.19% of 221 companies
in the Medical Diagnostics & Research industry
Industry Median: -12.7 vs LSE:LLAI: -11894.44

LungLife AI Net Margin % Historical Data

The historical data trend for LungLife AI's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LungLife AI Net Margin % Chart

LungLife AI Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial -3,065.38 -2,352.94 -3,808.16 -31,225.00 -11,877.78

LungLife AI Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,278.79 -45,362.50 -23,409.09 -12,350.00 -11,438.89

Competitive Comparison of LungLife AI's Net Margin %

For the Diagnostics & Research subindustry, LungLife AI's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LungLife AI's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, LungLife AI's Net Margin % distribution charts can be found below:

* The bar in red indicates where LungLife AI's Net Margin % falls into.



LungLife AI Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

LungLife AI's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-4.276/0.036
=-11,877.78 %

LungLife AI's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-2.059/0.018
=-11,438.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LungLife AI  (LSE:LLAI) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


LungLife AI Net Margin % Related Terms

Thank you for viewing the detailed overview of LungLife AI's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


LungLife AI (LSE:LLAI) Business Description

Traded in Other Exchanges
N/A
Address
2545 W. Hillcrest Drive, Suite 140, Thousand Oaks, CA, USA, 91320
LungLife AI Inc is a diagnostic company focused on the early detection of lung cancer from a simple blood draw enhanced by artificial intelligence. Its LungLB Test is a blood-based tool developed to provide clinicians the information needed to make informed decisions about the management of lung nodules and lung cancer.

LungLife AI (LSE:LLAI) Headlines

No Headlines